Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

Oruc Z, Kaplan MA, Geredeli C, Yildirim Sari N, Ozaslan E, Aytekin A, Tamer Elkiran E, Koca S, Dogan M, Turan N, Yuce O, Sevinc A, Ercelep O, Isikdogan A.

J BUON. 2019 Sep-Oct;24(5):1876-1883.

2.

The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.

Ali Kaplan M, Oruc Z, Gumus M, Ozaydın S, Elkiran ET, Dinc NS, Sakin A, Berk V, Akman T, Aytekin A, Yazilitas D, Dane F, Imamoglu GI, Cubukcu E, Isikdogan A.

J BUON. 2019 May-Jun;24(3):1081-1086.

3.

Effect of exercise on colorectal cancer prevention and treatment.

Oruç Z, Kaplan MA.

World J Gastrointest Oncol. 2019 May 15;11(5):348-366. doi: 10.4251/wjgo.v11.i5.348. Review.

4.

An update on the currently available and future chemotherapy for treating bone metastases in breast cancer patients.

Oruç Z, Kaplan MA, Arslan Ç.

Expert Opin Pharmacother. 2018 Aug;19(12):1305-1316. doi: 10.1080/14656566.2018.1504922. Epub 2018 Aug 21. Review.

PMID:
30129373
5.

Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder.

Erdem GU, Dogan M, Sakin A, Oruc Z, Yaman E, Yesil Cinkir H, Uysal M, Bozkurt O, Ozturk B, Aytekin A, Ozcelik M, Bahceci A, Cakiroglu U, Turhal S, Sahin S, Uncu D, Zengin N.

Oncol Res Treat. 2018;41(4):220-225. doi: 10.1159/000486598. Epub 2018 Mar 21. No abstract available.

6.

The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusion.

Düzköprü Y, Oruç Z, Kaplan MA, Ülkü R, Tanrıkulu Ç, Esmer D, Bırak A, Küçüköner M, Urakçı Z, Işıkdoğan A.

Contemp Oncol (Pozn). 2017;21(3):213-217. doi: 10.5114/wo.2017.70111. Epub 2017 Sep 29.

7.

Inducible CTCF insulator delays the IgH 3' regulatory region-mediated activation of germline promoters and alters class switching.

Braikia FZ, Oudinet C, Haddad D, Oruc Z, Orlando D, Dauba A, Le Bert M, Khamlichi AA.

Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):6092-6097. doi: 10.1073/pnas.1701631114. Epub 2017 May 22.

8.

Functional anatomy of the immunoglobulin heavy chain 3΄ super-enhancer needs not only core enhancer elements but also their unique DNA context.

Le Noir S, Boyer F, Lecardeur S, Brousse M, Oruc Z, Cook-Moreau J, Denizot Y, Cogné M.

Nucleic Acids Res. 2017 Jun 2;45(10):5829-5837. doi: 10.1093/nar/gkx203.

9.

Central nervous system metastatic epithelial ovarian cancer. Clinical parameters and prognostic factors: a multicenter study of Anatolian Society of Medical Oncology.

Seber S, Turkmen E, Harputoğlu H, Yeşil H, Arpacι E, Menekşe S, Pilancι K, Oruç Z, Taskoylu BY, Gumusay O, Aksoy A, Karaagac M, Ozarslan E, Yetisyigit T.

Eur J Gynaecol Oncol. 2017;38(2):227-231.

PMID:
29953785
10.

First Membrane Proximal External Region-Specific Anti-HIV1 Broadly Neutralizing Monoclonal IgA1 Presenting Short CDRH3 and Low Somatic Mutations.

Benjelloun F, Oruc Z, Thielens N, Verrier B, Champier G, Vincent N, Rochereau N, Girard A, Jospin F, Chanut B, Genin C, Cogné M, Paul S.

J Immunol. 2016 Sep 1;197(5):1979-88. doi: 10.4049/jimmunol.1600309. Epub 2016 Aug 1.

11.

Deciphering the importance of the palindromic architecture of the immunoglobulin heavy-chain 3' regulatory region.

Saintamand A, Vincent-Fabert C, Garot A, Rouaud P, Oruc Z, Magnone V, Cogné M, Denizot Y.

Nat Commun. 2016 Feb 17;7:10730. doi: 10.1038/ncomms10730.

12.

Sequential activation and distinct functions for distal and proximal modules within the IgH 3' regulatory region.

Garot A, Marquet M, Saintamand A, Bender S, Le Noir S, Rouaud P, Carrion C, Oruc Z, Bébin AG, Moreau J, Lebrigand K, Denizot Y, Alt FW, Cogné M, Pinaud E.

Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1618-23. doi: 10.1073/pnas.1514090113. Epub 2016 Feb 1.

13.

IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition.

Oruc Z, Oblet C, Boumediene A, Druilhe A, Pascal V, Le Rumeur E, Cuvillier A, El Hamel C, Lecardeur S, Leanderson T, Morelle W, Demengeot J, Aldigier JC, Cogné M.

J Am Soc Nephrol. 2016 Sep;27(9):2748-61. doi: 10.1681/ASN.2015080911. Epub 2016 Jan 29.

14.

A plasma cell differentiation quality control ablates B cell clones with biallelic Ig rearrangements and truncated Ig production.

Srour N, Chemin G, Tinguely A, Ashi MO, Oruc Z, Péron S, Sirac C, Cogné M, Delpy L.

J Exp Med. 2016 Jan 11;213(1):109-22. doi: 10.1084/jem.20131511. Epub 2015 Dec 14.

15.

Complete cis Exclusion upon Duplication of the Eμ Enhancer at the Immunoglobulin Heavy Chain Locus.

Puget N, Leduc C, Oruc Z, Moutahir M, Le Bert M, Khamlichi AA.

Mol Cell Biol. 2015 Jul;35(13):2231-41.

16.

B-cell receptor signal strength influences terminal differentiation.

Lechouane F, Bonaud A, Delpy L, Casola S, Oruc Z, Chemin G, Cogné M, Sirac C.

Eur J Immunol. 2013 Mar;43(3):619-28. doi: 10.1002/eji.201242912. Epub 2013 Jan 24.

17.

Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia.

Coulon S, Dussiot M, Grapton D, Maciel TT, Wang PH, Callens C, Tiwari MK, Agarwal S, Fricot A, Vandekerckhove J, Tamouza H, Zermati Y, Ribeil JA, Djedaini K, Oruc Z, Pascal V, Courtois G, Arnulf B, Alyanakian MA, Mayeux P, Leanderson T, Benhamou M, Cogné M, Monteiro RC, Hermine O, Moura IC.

Nat Med. 2011 Oct 23;17(11):1456-65. doi: 10.1038/nm.2462.

PMID:
22019886
18.

Gammopathy with IgA mesangial deposition provides a monoclonal model of IgA nephritogenicity and offers new insights into its molecular mechanisms.

Boumediene A, Oblet C, Oruc Z, Duchez S, Morelle W, Huynh A, Pourrat J, Aldigier JC, Cogné M.

Nephrol Dial Transplant. 2011 Dec;26(12):3930-7. doi: 10.1093/ndt/gfr131. Epub 2011 Mar 31.

PMID:
21459784
19.

Sense transcription through the S region is essential for immunoglobulin class switch recombination.

Haddad D, Oruc Z, Puget N, Laviolette-Malirat N, Philippe M, Carrion C, Le Bert M, Khamlichi AA.

EMBO J. 2011 Apr 20;30(8):1608-20. doi: 10.1038/emboj.2011.56. Epub 2011 Mar 4.

20.

Replacement of Igamma3 germ-line promoter by Igamma1 inhibits class-switch recombination to IgG3.

Oruc Z, Boumédiène A, Le Bert M, Khamlichi AA.

Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20484-9. Epub 2007 Dec 11.

21.

Sequence dependence of chromosomal R-loops at the immunoglobulin heavy-chain Smu class switch region.

Huang FT, Yu K, Balter BB, Selsing E, Oruc Z, Khamlichi AA, Hsieh CL, Lieber MR.

Mol Cell Biol. 2007 Aug;27(16):5921-32. Epub 2007 Jun 11.

22.

Germ line transcription in mice bearing neor gene downstream of Igamma3 exon in the Ig heavy chain locus.

Samara M, Oruc Z, Dougier HL, Essawi T, Cogné M, Khamlichi AA.

Int Immunol. 2006 Apr;18(4):581-9. Epub 2006 Feb 28.

PMID:
16507599
23.

Immunoglobulin class-switch recombination in mice devoid of any S mu tandem repeat.

Khamlichi AA, Glaudet F, Oruc Z, Denis V, Le Bert M, Cogné M.

Blood. 2004 May 15;103(10):3828-36. Epub 2004 Feb 12.

PMID:
14962903

Supplemental Content

Support Center